We used doxorubicin because the mechanism of action of doxorubicin is well characterized.41 Expression of IGPR-1 in HT29 and HCT116 cells increased the resistance of tumor cells to the cytotoxic effect of doxorubicin (Figure 6a). This evidence concerns the gene TMIGD2 and neoplasm.